The "chicken little" of renal stent trials: The CORAL trial in perspective

JACC: Cardiovascular Interventions

Volumn 7, Issue 1, 2014, Pages 111-113

  White, Christopher J ^a   King III, Spencer B ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; DIURETIC AGENT;

ANGIOGRAPHY; ANTIHYPERTENSIVE THERAPY; EDITORIAL; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; PRIORITY JOURNAL; RENAL ARTERY; RENAL ARTERY STENT; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; ANGIOPLASTY; ANTICOAGULANT THERAPY; PRACTICE GUIDELINE; RENAL ARTERY STENTING;

ANGIOPLASTY; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION, RENOVASCULAR; PATIENT SELECTION; PROSTHESIS DESIGN; RENAL ARTERY OBSTRUCTION; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84892994264     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.12.002     Document Type: Editorial

References (8)

1. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. In press.
2. Krumholz HM. Treating renal artery stenosis: skip the stent. NEJM Journal Watch. Available at: http://www.jwatch.org/na32899/2013/11/18/treating-renal- artery-stenosis-skip-stent. Accessed December 10, 2013.
3. A.T. Hirsch, Z.J. Haskal, and N.R. Hertzer et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation J Am Coll Cardiol 47 2006 1239 1312
4. R. Subramanian, C.J. White, and K. Rosenfield et al. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses Catheter Cardiovasc Interv 64 2005 480 486 (Pubitemid 40463446)
5. J. Mitchell, R. Subramanian, and C. White et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement Catheter Cardiovasc Interv 69 2007 685 689 (Pubitemid 46581257)
6. F. Mangiacapra, C. Trana, and G. Sarno et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension Circ Cardiovasc Interv 3 2010 537 542
7. M.A. Leesar, J. Varma, and A. Shapira et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography J Am Coll Cardiol 53 2009 2363 2371
8. M.S. Lauer, and R.B. D'Agostino Sr The randomized registry trial - the next disruptive technology in clinical research? N Engl J Med 369 2013 1579 1581